Education
About Us
Working with TipRanks
Follow Us
Sangamo Biosciences (SGMO)
NASDAQ:SGMO
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 57.80M | $ 176.23M | $ 111.30M | $ 110.70M | $ 118.19M |
| Gross Profit | $ 57.80M | $ 176.23M | $ 99.19M | $ 110.70M | $ -62.45M |
| Operating Income | $ -103.97M | $ -274.00M | $ -201.28M | $ -183.34M | $ -129.55M |
| EBITDA | $ -89.09M | $ -96.80M | $ -189.17M | $ -165.70M | $ -123.87M |
| Net Income | $ -97.94M | $ -257.83M | $ -192.28M | $ -178.29M | $ -121.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 41.92M | $ 81.00M | $ 277.63M | $ 376.55M | $ 641.42M |
| Total Assets | $ 101.64M | $ 165.32M | $ 562.51M | $ 721.92M | $ 938.55M |
| Total Debt | $ 30.57M | $ 38.10M | $ 43.11M | $ 48.08M | $ 42.09M |
| Net Debt | $ -11.35M | $ -7.10M | $ -57.34M | $ -130.79M | $ -89.24M |
| Total Liabilities | $ 78.86M | $ 82.43M | $ 267.55M | $ 346.58M | $ 441.18M |
| Stockholders' Equity | $ 22.77M | $ 82.89M | $ 294.96M | $ 375.34M | $ 498.23M |
| Cash Flow | |||||
| Free Cash Flow | $ -67.41M | $ -246.00M | $ -243.80M | $ -256.53M | $ 155.16M |
| Operating Cash Flow | $ -67.14M | $ -224.84M | $ -223.63M | $ -233.25M | $ 169.88M |
| Investing Cash Flow | $ 37.52M | $ 153.53M | $ 59.28M | $ 248.20M | $ -271.63M |
| Financing Cash Flow | $ 28.38M | $ 14.59M | $ 84.66M | $ 32.86M | $ 153.10M |
Sangamo Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.